TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 66 filers reported holding TERNS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,752,050 | -44.6% | 348,320 | -3.7% | 0.00% | -100.0% |
| Q2 2023 | $3,164,132 | +385.2% | 361,615 | +556.5% | 0.00% | – |
| Q1 2023 | $652,135 | +102.8% | 55,079 | +74.3% | 0.00% | – |
| Q4 2022 | $321,616 | +153.2% | 31,593 | +46.9% | 0.00% | – |
| Q3 2022 | $127,000 | +252.8% | 21,504 | +49.6% | 0.00% | – |
| Q2 2022 | $36,000 | -88.4% | 14,373 | -86.3% | 0.00% | – |
| Q1 2022 | $311,000 | -60.7% | 104,822 | -6.4% | 0.00% | – |
| Q4 2021 | $792,000 | -35.0% | 112,036 | -4.2% | 0.00% | – |
| Q3 2021 | $1,219,000 | +14.6% | 116,916 | +34.7% | 0.00% | – |
| Q2 2021 | $1,064,000 | -47.3% | 86,783 | -5.5% | 0.00% | – |
| Q1 2021 | $2,019,000 | – | 91,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,099,309 | $13,015,819 | 9.59% |
| VR Adviser, LLC | 3,619,522 | $42,855,140 | 8.37% |
| Vivo Capital, LLC | 6,657,992 | $78,830,625 | 5.47% |
| Fairmount Funds Management LLC | 2,040,000 | $24,153,600 | 4.15% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $8,457,134 | 3.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 667,922 | $7,908,196 | 3.26% |
| Ikarian Capital, LLC | 721,341 | $8,540,677 | 1.94% |
| Orbimed Advisors | 7,619,135 | $90,210,558 | 1.77% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,448,275 | $40,827,576 | 1.72% |
| CROSSPOINT FINANCIAL, LLC | 12,054 | $142,719 | 1.54% |